Latest Insider Transactions at Amylyx Pharmaceuticals, Inc. (AMLX)
This section provides a real-time view of insider transactions for Amylyx Pharmaceuticals, Inc. (AMLX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Amylyx Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Amylyx Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 06
2022
|
George M Milne Jr |
BUY
Open market or private purchase
|
Direct |
26,315
+10.62%
|
$499,985
$19.0 P/Share
|
|
Jan 06
2022
|
Patrick D Yeramian Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,333
+12.07%
|
-
|
|
Jan 06
2022
|
Isaac Cheng Director |
BUY
Open market or private purchase
|
Direct |
6,578
+50.0%
|
$124,982
$19.0 P/Share
|
|
Jan 06
2022
|
Isaac Cheng Director |
BUY
Conversion of derivative security
|
Indirect |
10,415,650
+29.62%
|
-
|
|
Jan 06
2022
|
Paul R. Fonteyne |
BUY
Open market or private purchase
|
Direct |
3,947
+50.0%
|
$74,993
$19.0 P/Share
|